Careers
Dr. Namitha Kumar's Profile
MA, PhD
Namitha A Kumar has a PhD in psychology from the National Institute of Advanced Studies (NIAS) focusing on the cognitive aspects of disability. She works in the field of rare, genetic disorders and currently, develops all the medical content for the Open Platform for Rare Diseases (OPFORD).
Written / Edited / Medically Reviewed
Long-term Treatment With Blood Thinner Delays Onset of Alzheimer’s
New research study proves how blood thinner Dabigatran delays the pathogenesis of Alzheimer’s disease in mouse models.
Common Genetic Mutations Found to be the Cause of Several Cancers
A single mutation in splicing factor 3b subunit gene (SF3B1) is the underlying cause of several cancers. This key discovery has therapeutic underpinnings, which can include using CRISPR to correct the rogue mutation and reverse the cancers
World's First Gene Therapy for a Rare, Deadly Liver Disorder
Hope for rare, deadly liver disorder with gene therapy has been developed. World's first gene therapy helps GSD patient community to get off the cornstarch dependency and maintain normal glycemic controls has been developed.
Cancer Cells Influence Neighbor Cells Causing Metastasis
Do cancer cells influence healthy cells? Yes, cancer cells influence healthy cells. A new study shows that cancer cells cause neighboring cells in the tumor microenvironment to regress into stem-cell-like states and metastasize.
Liquid Biopsies Enable Better Outcomes for Cancers
Liquid biopsies enable close monitoring of cancers in a minimally non-invasive method. Also, can detect, characterize, and monitor cancers much earlier than conventional methods. Liquid biopsies could soon become a routine test for preventive cancer screening.
